TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling

[1]  Q. Wang,et al.  Preventive and remedial application of etanercept attenuate monocrotaline‐induced pulmonary arterial hypertension , 2016, International journal of rheumatic diseases.

[2]  Yan-ting Zhu,et al.  Inhibition of Notch3 prevents monocrotaline-induced pulmonary arterial hypertension , 2015, Experimental Lung Research.

[3]  A. Harris,et al.  A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors , 2015, Clinical Cancer Research.

[4]  A. Bullock,et al.  Small Molecules Dorsomorphin and LDN-193189 Inhibit Myostatin/GDF8 Signaling and Promote Functional Myoblast Differentiation* , 2014, The Journal of Biological Chemistry.

[5]  P. Sarnow,et al.  Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension , 2014, The Journal of experimental medicine.

[6]  Wei Wang,et al.  Soluble Jagged1 Inhibits Pulmonary Hypertension by Attenuating Notch Signaling , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[7]  H. Jo,et al.  Anti-Inflammatory and Antiatherogenic Role of BMP Receptor II in Endothelial Cells , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[8]  C. Piantadosi,et al.  CCR2 deficiency, dysregulation of Notch signaling, and spontaneous pulmonary arterial hypertension. , 2013, American journal of respiratory cell and molecular biology.

[9]  A. Bullock,et al.  A New Class of Small Molecule Inhibitor of BMP Signaling , 2013, PloS one.

[10]  K. Horiuchi,et al.  Systemic Overexpression of TNFα-converting Enzyme Does Not Lead to Enhanced Shedding Activity In Vivo , 2013, PloS one.

[11]  Zhaohua Zhang,et al.  Mesenchymal stem cell prevention of vascular remodeling in high flow-induced pulmonary hypertension through a paracrine mechanism. , 2012, International immunopharmacology.

[12]  J. Ge,et al.  Atorvastatin prevents dehydromonocrotaline-induced pulmonary hypertension in beagles , 2012, Experimental lung research.

[13]  W. Ouwehand,et al.  Cross-domain inhibition of TACE ectodomain , 2011, Proceedings of the National Academy of Sciences.

[14]  Huai-liang Wang,et al.  Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated rats , 2011, Acta Pharmacologica Sinica.

[15]  R. Trembath,et al.  Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension , 2010, Circulation.

[16]  H. Verspaget,et al.  Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. , 2010, Cancer research.

[17]  N. Voelkel,et al.  Formation of Plexiform Lesions in Experimental Severe Pulmonary Arterial Hypertension , 2010, Circulation.

[18]  Samy Lamouille,et al.  TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling. , 2009, Molecular cell.

[19]  R. Trembath,et al.  Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells* , 2009, The Journal of Biological Chemistry.

[20]  M. Humbert,et al.  Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension , 2009, European Respiratory Journal.

[21]  N. Morrell,et al.  Altered Bone Morphogenetic Protein and Transforming Growth Factor-β Signaling in Rat Models of Pulmonary Hypertension: Potential for Activin Receptor-Like Kinase-5 Inhibition in Prevention and Progression of Disease , 2009, Circulation.

[22]  R. Trembath,et al.  Mutations in Bone Morphogenetic Protein Type II Receptor Cause Dysregulation of Id Gene Expression in Pulmonary Artery Smooth Muscle Cells: Implications for Familial Pulmonary Arterial Hypertension , 2008, Circulation research.

[23]  Christopher C W Hughes,et al.  TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. , 2008, Blood.

[24]  D. Despres,et al.  Notch2 is required for the proliferation of cardiac neural crest‐derived smooth muscle cells , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[25]  A. Kurisaki,et al.  Activin induces long-lasting N-methyl-d-aspartate receptor activation via scaffolding PDZ protein activin receptor interacting protein 1 , 2008, Neuroscience.

[26]  H. Beppu,et al.  Bone Morphogenetic Protein (BMP) Type II Receptor Is Required for BMP-mediated Growth Arrest and Differentiation in Pulmonary Artery Smooth Muscle Cells* , 2008, Journal of Biological Chemistry.

[27]  R. Trembath,et al.  Functional Characterization of Bone Morphogenetic Protein Binding Sites and Smad1/5 Activation in Human Vascular Cells , 2008, Molecular Pharmacology.

[28]  R. Trembath,et al.  Regulation of bone morphogenetic protein signalling in human pulmonary vascular development , 2008, The Journal of pathology.

[29]  E. Gherardi,et al.  Eotaxin-1/CC Chemokine Ligand 11: A Novel Eosinophil Survival Factor Secreted by Human Pulmonary Artery Endothelial Cells1 , 2007, The Journal of Immunology.

[30]  M. Humbert,et al.  Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. , 2007, Human pathology.

[31]  W. Seeger,et al.  Dysregulated Bone Morphogenetic Protein Signaling in Monocrotaline-Induced Pulmonary Arterial Hypertension , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[32]  L. David,et al.  Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. , 2007, Blood.

[33]  R. Tuder,et al.  Pathology of pulmonary hypertension. , 2007, Clinics in chest medicine.

[34]  L. Lind,et al.  Etanercept reduces late endotoxin-induced pulmonary hypertension in the pig. , 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[35]  H. Ishibashi-Ueda,et al.  Increased plasma monocyte chemoattractant protein‐1 level in idiopathic pulmonary arterial hypertension , 2006, Respirology.

[36]  P. Vandenabeele,et al.  TNFR1‐ and TNFR2‐mediated signaling pathways in human kidney are cell type‐specific and differentially contribute to renal injury , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  J. Loscalzo,et al.  Increased Susceptibility to Pulmonary Hypertension in Heterozygous BMPR2-Mutant Mice , 2005, Circulation.

[38]  J. Knowles,et al.  Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension. , 2005, American journal of respiratory cell and molecular biology.

[39]  H. Beppu,et al.  Bone Morphogenetic Protein (BMP) Type II Receptor Deletion Reveals BMP Ligand-specific Gain of Signaling in Pulmonary Artery Smooth Muscle Cells* , 2005, Journal of Biological Chemistry.

[40]  N. Rudarakanchana,et al.  Dysfunctional Smad Signaling Contributes to Abnormal Smooth Muscle Cell Proliferation in Familial Pulmonary Arterial Hypertension , 2005, Circulation research.

[41]  M. Lambert,et al.  Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. , 2005, Combinatorial chemistry & high throughput screening.

[42]  K. Miyazono,et al.  BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[43]  B. Klonjkowski,et al.  Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. , 2004, Genes & development.

[44]  S. Dehm,et al.  SRC gene expression in human cancer: the role of transcriptional activation. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[45]  J. Arribas,et al.  The Shedding of Betaglycan Is Regulated by Pervanadate and Mediated by Membrane Type Matrix Metalloprotease-1* , 2004, Journal of Biological Chemistry.

[46]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[47]  T. Takizawa,et al.  Enhanced gene activation by Notch and BMP signaling cross-talk. , 2003, Nucleic acids research.

[48]  Wenli Wang,et al.  Determinants of Notch-3 Receptor Expression and Signaling in Vascular Smooth Muscle Cells: Implications in Cell-Cycle Regulation , 2002, Circulation research.

[49]  M. Goumans,et al.  Stimulation of Id1 Expression by Bone Morphogenetic Protein Is Sufficient and Necessary for Bone Morphogenetic Protein–Induced Activation of Endothelial Cells , 2002, Circulation.

[50]  N. Rudarakanchana,et al.  Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. , 2002, Human molecular genetics.

[51]  R. Trembath,et al.  Primary Pulmonary Hypertension Is Associated With Reduced Pulmonary Vascular Expression of Type II Bone Morphogenetic Protein Receptor , 2002, Circulation.

[52]  S. Hodge,et al.  Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.

[53]  R. Trembath,et al.  Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension , 2000, Nature Genetics.

[54]  A Cumano,et al.  A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. , 2000, Molecular cell.

[55]  J. R. Coleman,et al.  Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality. , 1999, Development.

[56]  B. Groves,et al.  Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. , 1994, The American journal of pathology.

[57]  W. Chung,et al.  Genetics and genomics of pulmonary arterial hypertension. , 2013, Journal of the American College of Cardiology.

[58]  K. Miyazono,et al.  Bone morphogenetic protein receptors and signal transduction. , 2010, Journal of biochemistry.

[59]  V. Salih,et al.  Bone morphogenetic protein receptors and bone morphogenetic protein signaling are controlled by tumor necrosis factor-alpha in human bone cells. , 2006, The international journal of biochemistry & cell biology.

[60]  R. Derynck,et al.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.

[61]  M. Fujita,et al.  Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[62]  M. Humbert,et al.  BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. , 2001, American journal of human genetics.

[63]  J. Inman,et al.  Bmc Cell Biology a Rapid and Sensitive Bioassay for the Simultaneous Measurement of Multiple Bone Morphogenetic Proteins. Identification and Quantification of Bmp4, Bmp6 and Bmp9 in Bovine and Human Serum , 2022 .